Page last updated: 2024-09-04

jte 522 and tegafur

jte 522 has been researched along with tegafur in 2 studies

Compound Research Comparison

Studies
(jte 522)
Trials
(jte 522)
Recent Studies (post-2010)
(jte 522)
Studies
(tegafur)
Trials
(tegafur)
Recent Studies (post-2010) (tegafur)
61175,8921,4332,088

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirose, F; Ikeda, Y; Nakamura, Y; Nishimura, G; Satake, K; Taguchi, T; Tsukuda, M; Yanoma, S1
Hirakawa, K; Nakazawa, K; Ohira, M; Sawada, T; Tendo, M; Yamada, N; Yashiro, M1

Other Studies

2 other study(ies) available for jte 522 and tegafur

ArticleYear
An experimental model of tumor dormancy therapy for advanced head and neck carcinoma.
    Japanese journal of cancer research : Gann, 2000, Volume: 91, Issue:11

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Biotransformation; Cell Division; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Organic Chemicals; Oxonic Acid; Probucol; Prodrugs; Prostaglandin-Endoperoxide Synthases; Pyridines; Tegafur; Telomerase; Xenograft Model Antitumor Assays

2000
A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
    Cancer letters, 2006, Dec-08, Volume: 244, Issue:2

    Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Benzenesulfonates; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oxazoles; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Tumor Cells, Cultured

2006